0001181431-14-037473.txt : 20141128
0001181431-14-037473.hdr.sgml : 20141127
20141128164211
ACCESSION NUMBER: 0001181431-14-037473
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141128
FILED AS OF DATE: 20141128
DATE AS OF CHANGE: 20141128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3960 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10032
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 3960 BROADWAY
CITY: NEW YORK
STATE: NY
ZIP: 10032
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALAFI CAPITAL CO LLC
CENTRAL INDEX KEY: 0001216017
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 141256102
MAIL ADDRESS:
STREET 1: PO BOX 7338
CITY: BERKELEY
STATE: CA
ZIP: 94707
4
1
rrd419474.xml
FORM 4 - ALAFI CAPITAL COMPANY, LLC
X0306
4
2014-11-28
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001216017
ALAFI CAPITAL CO LLC
8 ADMIRAL DRIVE, SUITE 324
EMERYVILLE
CA
94608
0
0
1
0
Common Stock
2014-11-28
4
P
0
35000
14.75
A
3594783
D
This Form 4 reports a private transaction in which Alafi Capital Company, LLC (of which Christopher Alafi, Ph.D., one of the Issuer's directors, is a managing partner) purchased 35,000 shares of the Issuer's common stock from Sharon Mates, Ph.D., the Issuer's Chairman, President and Chief Executive Officer.
/s/ Lawrence J. Hineline, Attorney-in-fact
2014-11-28